Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Endocrinology

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/EN.2005-0938PMID 16141388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation

  2005cited by this paper
• Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women

  2004cited by this paper
• Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.

  2004influential reference
• Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats.

  2004cited by this paper
• Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm.

  2004cited by this paper
• Increased oxidative stress in obesity and its impact on metabolic syndrome.

  2004cited by this paper
• Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload.

  2003cited by this paper
• Influence of diabetes mellitus on heart failure risk and outcome

  2003cited by this paper
• Cardiac lipid accumulation associated with diastolic dysfunction in obese mice.

  2003cited by this paper
• Cardiovascular effects of leptin and orexins.

  2003cited by this paper
• Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.

  2003cited by this paper
• Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease.

  2002cited by this paper
• Adaptation and maladaptation of the heart in diabetes: Part I: general concepts.

  2002cited by this paper
• Superoxide activates mitochondrial uncoupling proteins

  2002cited by this paper
• Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

  2002cited by this paper
• The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.

  2002cited by this paper
• Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart.

  2002cited by this paper
• Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms

  2002cited by this paper
• Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36.

  2002cited by this paper
• Alterations of the circadian clock in the heart by streptozotocin-induced diabetes.

  2002cited by this paper
• Superoxide Activates Mitochondrial Uncoupling Protein 2 from the Matrix Side

  2002cited by this paper
• Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association

  2002cited by this paper
• Cardiac carbohydrate metabolism in Zucker diabetic fatty rats.

  2002influential reference
• Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome.

  2001cited by this paper
• Lipotoxic heart disease in obese rats: implications for human obesity.

  2000cited by this paper
• Pathophysiological role of leptin in obesity-related hypertension.

  2000cited by this paper
• Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction.

  2000cited by this paper
• Cardiac dysfunction caused by myocardium-specific expression of a mutant thyroid hormone receptor.

  2000cited by this paper
• Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.

  2000cited by this paper
• Cardiac Abnormalities Associated with Morbid Obesity

  1998cited by this paper
• Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy

  1998cited by this paper
• Regulation of energy substrate metabolism in the diabetic heart.

  1997cited by this paper
• Developmental and hormonal regulation of sarcomeric myosin heavy chain gene family.

  1987cited by this paper
• Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals.

  1987cited by this paper

• Assessment of Maternal Cardiac Adaptations in Women with Gestational Diabetes Mellitus

  2026cites this paper
• Defining Metrics and the Framework for the Invasive Assessment of Patients with Presumed Coronary Microvascular and Vasomotor Dysfunction.

  2026cites this paper
• Posttranslational modifications in cardiac metabolic remodeling mediated by metabolites: Implications for disease pathology and therapeutic potential.

  2025cites this paper
• WBSCR16 is essential for mitochondrial 16S rRNA processing in mammals

  2025cites this paper
• Impaired cardiac branched-chain amino acid metabolism in a novel model of diabetic cardiomyopathy

  2025cites this paper
• MOTS-c in type 2 diabetes mellitus: From risk factors to cardiac complications and potential treatment.

  2025cites this paper
• Targeting glycogen clearance to treat diabetic cardiomyopathy

  2025cites this paper
• Metabolic Modulation of Pyruvate Dehydrogenase and Glucose Oxidationin Diabetic Cardiomyopathy: Pathways, Perspectives, and Potentials.

  2025cites this paper
• Cardiac substrate metabolism in type 2 diabetes

  2025cites this paper
• NLRP3 inflammasomes pathway: a key target for Metformin

  2025cites this paper
• Cardiac Energy Metabolism in Diabetes: Emerging Therapeutic Targets and Clinical Implications.

  2025cites this paper
• Guidelines for Diet-Induced Models of Cardiometabolic Syndrome.

  2025cites this paper
• Cardiac lipid droplets differ under pathological and physiological conditions

  2025cites this paper
• Growth Factor Receptor‐Binding Protein 10 Promotes High Glucose‐Induced H9c2 Cardiomyoblast Apoptosis via Inhibition of the ERK1/2 and JAK2/STAT3 Signaling Pathways

  2025cites this paper
• Lipotoxicity as a therapeutic target in the type 2 diabetic heart.

  2025cites this paper
• l-Arginine: A multifaceted regulator of diabetic cardiomyopathy.

  2025cites this paper
• Morphological Features of the Myocardium in db/db Mice with Genetically Determined Leptin Resistance and Glucose Metabolism Disorders after Systematic Administration of Recombinant Apolipoprotein A-I

  2025cites this paper
• The Role of Insulin Resistance in Cardiorenal Metabolic Syndrome.

  2025cites this paper
• Wnt/β-catenin signaling regulates cardiac Cx43 in a metabolic substrate-dependent manner

  2025cites this paper
• FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes

  2025cites this paper
• Effect of glycemic status on myocardial deformation and microvascular function in uncomplicated pediatric type 1 diabetes mellitus: cardiac magnetic resonance imaging

  2025cites this paper
• Simultaneous in vivo multi-organ fluxomics reveals divergent metabolic adaptations in liver, heart, and skeletal muscle during obesity

  2025cites this paper
• The impact of obesity on cardiac energy metabolism and efficiency in heart failure with preserved ejection fraction.

  2025cites this paper
• Myocardial pyruvate dehydrogenase kinase 4 drives sex-specific cardiac responses to endotoxemia

  2025cites this paper
• The Advanced Glycation End-Products (AGE)–Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases

  2025cites this paper
• Glycometabolic cardiac dysfunction in HFpEF: lessons from multi-omics studies.

  2025cites this paper
• The role of lysine acetylation in metabolic sensing and proteostasis.

  2025cites this paper
• Ventricular arrhythmogenic remodelling in diet‐induced metabolic syndrome driven by right‐to‐left regional differences in action potential duration and dominant frequency gradients

  2025cites this paper
• Cardiometabolic Phenotype in HFpEF: Insights from Murine Models

  2025cites this paper
• Research Progress on Metabolic Disorders Associated with Diabetic Cardiomyopathy

  2025cites this paper
• The need to redefine diabetic cardiomyopathy as a unique clinical entity that requires pharmacotherapy

  2025cites this paper
• Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction

  2024cites this paper
• Insulin–Heart Axis: Bridging Physiology to Insulin Resistance

  2024cites this paper
• Metabolomic Profiling Reveals That Exercise Lowers Biomarkers of Cardiac Dysfunction in Rats with Type 2 Diabetes

  2024cites this paper
• Investigating the Interplay between Cardiovascular and Neurodegenerative Disease

  2024cites this paper
• The role of acetylation in obesity-induced cardiac metabolic alterations

  2024cites this paper
• Research advances in the therapy of metabolic syndrome

  2024cites this paper
• Lipotoxicity-induced upregulation of FIS1 exacerbates mitochondrial fragmentation and promotes NLRP3-dependent pyroptosis in diabetic cardiomyopathy.

  2024cites this paper
• Effects of Gestational Diabetes Mellitus on Fetal Cardiac Morphology

  2024cites this paper
• The role of protein kinase D (PKD) in obesity: Lessons from the heart and other tissues.

  2024cites this paper
• Transcriptional control of cardiac energy metabolism in health and disease: Lessons from animal models.

  2024cites this paper
• Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology

  2024cites this paper
• Mitochondrial fatty acid oxidation is the major source of cardiac ATP production in heart failure with preserved ejection fraction.

  2024cites this paper
• The Relationship Between Cardiac Energy Metabolism and Cardiac Function in Obesity and Type 2 Diabetes: Revisiting a 2003 Diabetes Classic by Aasum et al.

  2024cites this paper
• Fetal Strain and Strain Rate Measured with Speckle Tracking Echocardiography in Maternal Diabetes: Systematic Review

  2024cites this paper
• Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond

  2024cites this paper
• Influence of gestational diabetes mellitus on subclinical myocardial dysfunction during pregnancy: A systematic review and meta-analysis.

  2023cites this paper
• mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy

  2023cites this paper
• Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy

  2023cites this paper
• The tissue‐specific metabolic effects of the PPARα agonist ciprofibrate in insulin‐resistant male individuals: a double‐blind, randomized, placebo‐controlled crossover study

  2023cites this paper
• Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells

  2023cites this paper
• The Link Between Obesity and Aging-Insights Into Cardiac Energy Metabolism.

  2023cites this paper
• The evaluation of fetal interventricular septum with M-mode and spectral tissue Doppler imaging in gestational diabetes mellitus: a case-control study

  2023cites this paper
• Rutin forestalls dysregulated cardiac bioenergetics in bisphenol A and dibutyl phthalate-exposed rats through PPARα and AMPK modulation

  2023cites this paper
• Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments

  2023cites this paper
• From Obesity-Induced Low-Grade Inflammation to Lipotoxicity and Mitochondrial Dysfunction: Altered Multi-Crosstalk between Adipose Tissue and Metabolically Active Organs

  2023cites this paper
• WBSCR16 Determines Metabolic Flexibility Via Regulating Mitochondrial 16S rRNA Maturation

  2023cites this paper
• Energy metabolism: A critical target of cardiovascular injury.

  2023cites this paper
• Effects of melatonin on cardiac metabolic reprogramming in doxorubicin‐induced heart failure rats: A metabolomics study for potential therapeutic targets

  2023cites this paper
• Fetal Cardiac Function at Midgestation in Women Who Subsequently Develop Gestational Diabetes.

  2023cites this paper
• Feeding-induced hepatokines and crosstalk with multi-organ: A novel therapeutic target for Type 2 diabetes

  2023cites this paper
• Myocardial tissue remodeling in early adult obesity and its association with regional adipose tissue distribution and ectopic fat deposits: a prospective study

  2023cites this paper
• Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation

  2023cites this paper
• Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db/db mice

  2023cites this paper
• The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure

  2023cites this paper
• Visualizing increased uptake of [18F]FDG and [18F]FTHA in kidneys from obese high-fat diet fed C57BL/6J mice using PET/CT ex vivo

  2023cites this paper
• Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery

  2023cites this paper
• Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice

  2023cites this paper
• The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy

  2023cites this paper
• Effects of Short Term Adiponectin Receptor Agonism on Cardiac Function and Energetics in Diabetic db/db Mice

  2022cites this paper
• The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy

  2022cites this paper
• Diabetes Mellitus and Heart Failure

  2022cites this paper
• The need for adjusting experimental models to meet clinical reality.

  2022cites this paper
• Diabetes disturbs functional adaptation of the remote myocardium after ischemia/reperfusion.

  2022cites this paper
• Insulin‐like growth factor II receptor alpha overexpression in heart aggravates hyperglycemia‐induced cardiac inflammation and myocardial necrosis

  2022cites this paper
• Guidelines on models of diabetic heart disease

  2022influential citation
• Animal Models of Dysregulated Cardiac Metabolism

  2022cites this paper
• Role of Long Non-Coding RNA in Regulating ER Stress Response on the Progression of Diabetic Complications.

  2022cites this paper
• Short-Chain Carbon Sources

  2022cites this paper
• Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets

  2022cites this paper
• The impact of age, type 2 diabetes and hypertension on heart rate variability during rest and exercise at increasing levels of heat stress

  2022cites this paper
• Evaluation of Fetal Cardiac Geometry and Contractility in Gestational Diabetes Mellitus by Two-Dimensional Speckle-Tracking Technology

  2022cites this paper
• Branched-Chain Amino Acid Metabolism in the Failing Heart

  2022cites this paper
• Metabonomic Characteristics of Myocardial Diastolic Dysfunction in Type 2 Diabetic Cardiomyopathy Patients

  2022cites this paper
• Metabolic, structural and biochemical changes in diabetes and the development of heart failure

  2022cites this paper
• Pyruvate Dehydrogenase Complex and Glucose Oxidation as a Therapeutic Target in Diabetic Heart Disease

  2022cites this paper
• Overexpression of NOX2 Exacerbates AngII-Mediated Cardiac Dysfunction and Metabolic Remodelling

  2022cites this paper
• The multifaceted roles of ER and Golgi in metabolic cardiomyopathy

  2022cites this paper
• Unveiling the Vital Role of Long Non-Coding RNAs in Cardiac Oxidative Stress, Cell Death, and Fibrosis in Diabetic Cardiomyopathy

  2022cites this paper
• Diabetic cardiomyopathy: Clinical phenotype and practice

  2022influential citation
• Acute effects of high intensity training on cardiac function: a pilot study comparing subjects with type 2 diabetes to healthy controls

  2022cites this paper
• Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy.

  2021cites this paper
• Three‐dimensional echocardiography and cardiac strain imaging in women with gestational diabetes mellitus

  2021cites this paper
• Concurrent diabetes and heart failure: interplay and novel therapeutic approaches.

  2021cites this paper
• FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity.

  2021cites this paper
• Cardiac transcriptomic remodeling in metabolic syndrome

  2021cites this paper
• Cardiac Energy Metabolism in Heart Failure

  2021cites this paper
• BH4 Increases nNOS Activity and Preserves Left Ventricular Function in Diabetes.

  2021cites this paper
• Insulin Signaling In the Heart.

  2021cites this paper
• Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy

  2021cites this paper